Evidence-Based Comparison: What Clinical Trials Reveal
Understanding What's Best: Mounjaro or Wegovy for Weight Loss Results
When determining what's best between Mounjaro or Wegovy, understanding their different mechanisms of action provides crucial insight. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone to reduce appetite and promote satiety after smaller meals. Mounjaro contains tirzepatide, which works as a dual agonist targeting both GIP and GLP-1 receptors, potentially offering a broader approach to appetite regulation. Both are prescription-only medicines that require clinical assessment and work alongside lifestyle modifications.
The question of what's best—Mounjaro or Wegovy—often depends on individual patient factors that your prescriber will evaluate during your clinical assessment. Both treatments follow structured dose escalation protocols, starting with lower doses and gradually increasing to maintenance levels over 16-20 weeks. Your medical history, current medications, and weight management goals all influence which treatment may be most suitable. Our clinical team at EverydayMeds can guide you through this decision-making process during your consultation.
Wegovy Pricing and Value Proposition for UK Patients
Understanding the investment required helps inform what's best between Mounjaro or Wegovy for your budget and treatment timeline. Wegovy pricing at EverydayMeds starts with the 0.25mg starter dose at £79.99, progressing through 0.5mg (£94.99), 1mg (£99.99), 1.7mg (£139.99), to the maintenance 2.4mg dose at £209.99. New customers can apply discount code FIRST40 at checkout, whilst returning patients use DOSE25 to access these competitive prices.
Our bundle options provide convenience for those committed to their weight management journey, with options like the Intro Trio (0.25mg, 0.5mg, 1mg) at £299.99 for three months of step-up dosing. The Progress Duo combines 0.5mg and 1mg pens for £189.99, whilst our Ultimate Stability Trio offers three months of maintenance 2.4mg supply for £649.99. These bundles eliminate the need for multiple orders and ensure uninterrupted treatment continuity throughout your dose escalation phase.
Clinical Evidence: STEP Trial Results for Wegovy
When evaluating what's best—Mounjaro or Wegovy—the published STEP trial data provides robust evidence for Wegovy's effectiveness. The landmark STEP 1 trial, published by Wilding et al. in NEJM 2021, demonstrated that patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks, compared to 2.4% with placebo. STEP 3 showed even greater results of approximately 16% when combined with intensive behavioural therapy.
Long-term sustainability data from STEP 5 revealed approximately clinically studied weight loss maintained at two years, whilst the SELECT cardiovascular outcomes trial demonstrated a 20% reduction in major cardiovascular events. These results represent what patients achieved in controlled clinical trial conditions and individual results may vary based on adherence to lifestyle modifications and treatment protocols.
How Wegovy Works: GLP-1 Receptor Mechanism
Wegovy functions as a GLP-1 receptor agonist, mimicking the action of glucagon-like peptide-1, a hormone naturally produced in your intestines after eating. This mechanism helps regulate blood sugar levels whilst significantly reducing appetite and promoting feelings of fullness after consuming smaller portions. The medication works on specific areas of the brain involved in appetite control, potentially reducing food cravings and the urge to overeat. Unlike some weight management approaches that rely solely on willpower, Wegovy addresses the biological factors that influence hunger and satiety. This scientific approach to weight management represents a significant advancement in understanding how hormonal pathways affect body weight regulation.
Your Wegovy Journey: Assessment to Delivery Process
Starting your weight management journey with Wegovy begins with our streamlined three-minute online clinical assessment, designed to evaluate your suitability for this prescription-only medicine. Our qualified prescribers review your medical history, current medications, and weight management goals, typically providing decisions within three working days, or 24 hours with our express service. Once approved, your Wegovy pens are dispatched via next-day delivery using specialist cold-chain packaging to maintain the medication's effectiveness throughout transit. Our GPhC-registered pharmacy (#9012878) ensures all medications meet strict quality standards from storage through to your doorstep. This comprehensive process ensures you receive genuine, properly stored medication with full clinical oversight throughout your treatment.
Storage and Practical Considerations for Wegovy
Proper storage plays a crucial role in maintaining Wegovy's effectiveness and offers one advantage when comparing what's best between Mounjaro or Wegovy. Wegovy pens must be stored in the refrigerator at 2-8°C before first use, but once removed, they remain stable at room temperature (below 30°C) for up to six weeks, compared to Mounjaro's 21-day room temperature limit. This extended stability makes Wegovy more convenient for travel or situations where refrigeration isn't consistently available. The FlexTouch pen design provides precise dosing with an easy-to-use interface that doesn't require online pharmacy needle attachment. Your dose escalation schedule follows a specific 16-week protocol, starting at 0.25mg weekly and increasing every four weeks until reaching the 2.4mg maintenance dose. Understanding these practical aspects helps ensure treatment success and optimal results throughout your weight management journey.
Comparing Dual-Action vs Single-Action Mechanisms
The fundamental difference in what's best between Mounjaro or Wegovy lies in their receptor targeting approaches and clinical trial populations. Mounjaro's tirzepatide targets both GIP and GLP-1 receptors, offering a dual-action approach that some researchers suggest may provide enhanced metabolic benefits. However, both medications demonstrated significant effectiveness in their respective clinical trials, though direct head-to-head comparisons aren't available due to different trial designs and patient populations.
Your prescriber considers multiple factors when determining what's best—Mounjaro or Wegovy—including your medical history, previous weight management attempts, and individual response patterns. Both treatments require the same commitment to lifestyle modifications, including reduced-calorie diet and increased physical activity. The choice often comes down to individual patient factors, practical considerations like storage requirements, and prescriber experience with each medication for your specific situation.
Making Your Decision: Both Available from EverydayMeds
Both Wegovy and Mounjaro are available from EverydayMeds, ensuring you have access to whichever treatment your prescriber determines most appropriate for your weight management goals. Our clinical team evaluates your individual circumstances during the assessment process, considering factors like medical history, lifestyle, and treatment preferences to guide this important decision. Whether you're prescribed Wegovy or Mounjaro, our GPhC-registered pharmacy provides the same high-quality service, cold-chain delivery, and ongoing clinical support. Starting your consultation today allows our prescribers to review your suitability and recommend the most appropriate treatment option. Visit https://everydaymeds.co.uk/collections/wegovy to begin your clinical assessment, and remember to apply discount code FIRST40 at checkout for the best available pricing on your weight management journey.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
